[Salazosulfapyridine-induced lupus erythematosus syndrome in ulcerative colitis (author's transl)].
In a 25-year old woman with ulcerative colitis a lupus erythematosus syndrome occurred during treatment with salazosulfapyridine. The connection with medication was ascertained by reexposition. Some of the systemic complications of ulcerative colitis may possibly be due to the salazosulfapyridine medication.
D000328:Adult; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced* / Q000209:etiology; D011239:Prednisolone / Q000627:therapeutic use; D012460:Sulfasalazine / Q000009:adverse effects* / Q000627:therapeutic use
D012460:Sulfasalazine; D011239:Prednisolone
Salazosulfapyridin-induziertes Lupus-erythematodes-Syndrom bei Colitis ulcerosa.